Journal of Medical Virology

Article	Citations
Comparison of the pediatric hospitalizations due to COVID‐19 and H1N1pdm09 virus infections during the pandemic period	700
Diversity of picornaviruses detected in diarrheal samples from children in Belém, Brazilian Amazon (1982–2019)	476
The potential rationale of COVID‐19 vaccine‐induced myopericarditis	457
Comparative analyses of small molecule and antibody inhibition on glycoprotein‐mediated entry of Měnglà virus with other filoviruses	405
Change in willingness to COVID‐19 vaccination in China: Two online surveys during the pandemic	254
Association between cytomegalovirus seropositivity and all‐cause mortality: An original cohort study	244
Molecular epidemiology of SARS‐CoV‐2 variants in circulation in the state of Maranhão, Brazil	218
Circulating rotavirus P[8]‐lineage IV, unlike P[8]‐lineage III, significantly related to nonsecretors status in Iranian children	201
Reconstruction of molecular evolution of human influenza A H1N1/2009 virus in Iran and neighboring countries	201
Seroprevalence of neutralizing antibodies against the respiratory syncytial virus in healthy adults in Guangzhou, southern China	192
On coming back, the scaring COVID‐19 concern. Addressing indoor microclimates with innovative and straightforward solutions to prevent SARS‐CoV2 spreading	177
Novel diarylpyrimidine subtypes as HIV‐1 nonnucleoside reverse transcriptase inhibitors with improved resistance profile	173
Comment on “The risk assessment of uveitis after COVID‐19 diagnosis”	164
Posttranslational modifications of ACE2 protein: Implications for SARS‐CoV‐2 infection and beyond	155
	147
Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID‐19 patients	129
Previous SARS‐CoV‐2 infection is linked to lower vaccination intentions	126
Significant neutralizing escapes of Omicron and its sublineages in SARS‐CoV‐2‐infected individuals vaccinated with inactivated vaccines	125
Better detection of Torque teno virus in children with leukemia by metagenomic sequencing than by quantitative PCR	117
SARS‐CoV‐2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID‐19 vaccine: Looking for correlates of protection	116
Cytomegalovirus seropositivity and its correlation with all‐cause mortality among US adults	113
Effects of baloxavir and oseltamivir antiviral therapy on the transmission of seasonal influenza in China: A mathematical modeling analysis	111
Dynamics of spreading of SARS‐CoV‐2 in a Belgian hemodialysis facility: The importance of the analysis of viral strains	108
Effect of the coronavirus pandemic on tumor markers	107
Public screening for COVID‐19 in Wuhan, China and beware of the antibody positive in women and tumor patients	106

Are bladder washing samples suitable for investigation of HPV infection in urinary bladder? Comparison in HPV prevalence between urine and washing samples	104
BK Polyomavirus DNAemia With a High DNA Load Is Associated With De Novo Donor‐Specific HLA Antibodies in Kidney Transplant Recipients	103
SARS‐CoV‐2 seroprevalence and vaccine coverage from August to November 2021: A nationally representative survey in Mexico	97
Repeat virological and serological profiles in hospitalized patients initially tested by nasopharyngeal RT‐PCR for SARS‐CoV‐2	92
Prisoners of variants, or free to act as prisoners of swabs? The case of Italy	92
Prolonged fecal shedding of SARS‐CoV‐2 in a young immunocompetent COVID‐19 patient: A case report and literature overview	91
Neutralization of B.1.617.2 variant through antibodies elicited by ChAdOx1‐S, BBIBP‐CorV, and Gam‐COVID‐Vac in an Argentinean cohort	88
No signs of “tripledemic” in Finnish children	87
Issue Information	85
	84
Issue Information	82
COVID‐19 and Oncofertility: No SARS‐CoV‐2 in Semen but Inflammation Seems to Affect Sperm Parameters	81
Comment on “A systematic review and meta‐analysis of herpes zoster occurrence/recurrence after COVID‐19 infection and vaccination”	81
Corrigendum	80
Risks of catching COVID‐19 according to vaccination status of healthcare workers during the SARS‐CoV‐2 Delta variant dominant period and their clinical characteristics	77
Erratum	76
Exploring the dynamics of the 2022 mpox outbreak in Canada	76
Rotavirus trends and distribution of genotypes before and during COVID‐19 pandemic era: Bangladesh, 2017–2021	75
Variants of concern responsible for SARS‐CoV‐2 vaccine breakthrough infections from India	73
Cell Culture of a Swine Genotype 4 Hepatitis E Virus Strain	72
ZNFX1 antisense RNA1 promotes antiviral innate immune responses via modulating ZNFX1 function	72
Cross‐sectional analysis reveals autoantibody signatures associated with COVID‐19 severity	70
Real‐world effectiveness of sotrovimab and remdesivir for early treatment of high‐risk hospitalized COVID‐19 patients: A propensity score adjusted retrospective cohort study	68
Correction to “Fullerene (C60 & C70)‐Meso‐Tris‐4‐Carboxyphenyl Porphyrin Dyads Inhibit Entry of Wild‐Type and Drug‐Resistant HIV‐1 Clades B and C”	68
Ramsay Hunt syndrome and concurrent varicella‐zoster virus meningitis in Denmark: A nationwide cohort study	67
Cytological features of human papillomavirus‐infected immature squamous metaplastic cells from cervical intraepithelial neoplasia grade 2	66
Identification of a new polyomavirus in distinct human populations and tissues	66
Cytomegalovirus‐RNA Accurately Identifies Clinically Significant Infection Needing Preemptive Therapy in Liver Transplanted Children: A Proof‐of‐Concept Study	66
Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID‐19	66
Influenza vaccination on SARS‐CoV‐2 infection risk: A subgroup analysis on geographic factor	65
Comparison of demographic and clinical characteristics of hospitalized COVID‐19 patients with severe/critical illness in the first wave versus the second wave	64
Azvudine and nirmatrelvir–ritonavir in hospitalized patients with moderate‐to‐severe COVID‐19: Emulation of a randomized target trial	63
Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID‐19 booster dose in persons with HIV	63
A bivalent vaccine containing D614G and BA.1 spike trimer proteins or a BA.1 spike trimer protein booster shows broad neutralizing immunity	62
Establishment of nucleic acid sensing pathways‐based model in predicting response to immunotherapy and targeted drug in hepatitis virus‐related hepatocellular carcinoma	61
Zoonotic spillover and extreme weather events drive the global outbreaks of airborne viral emerging infectious diseases	61
Outcomes of definitive local therapy with intensity‐modulated radiation therapy in elderly patients ≥70 years with HPV‐associated oropharyngeal cancer	61
TLR3 polymorphisms are associated with the severity of hand, foot, and mouth disease caused by enterovirus A71 in a Chinese children population	61
Issue Information	61
Infection by SARS‐CoV‐2 with alternate frequencies of mRNA vaccine boosting	61
Human papillomavirus genotype concordance between Anyplex II HPV28 and linear array HPV genotyping test in anogenital samples	60
Melatonin use for SARS‐CoV‐2 infection: Time to diversify the treatment portfolio	59
Efficient recall of SARS‐CoV‐2 variant‐reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters	59
Epidemiological characteristics of norovirus infection in pediatric patients during the COVID‐19 pandemic	58
An exploratory study on the propagation of SARS‐CoV‐2 variants: Omicron is the most predominant variant	57
Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patients	57
Advances in laboratory detection methods and technology application of SARS‐CoV‐2	57
Booster vaccination strategy: Necessity, immunization objectives, immunization strategy, and safety	56
Statistical modeling, dichotomization, and nonlinearity	56
Detection of SARS‐CoV‐2 virus in middle ear effusions and its association with otitis media with effusion	56

Impact of hepatitis B surface antigen positive grafts on liver transplantation in patients with benign and malignant liver disease	55
RT‐RPA Assisted CRISPR/Cas12a Based One‐Pot Rapid and Visual Detection of the Pan‐Dengue Virus	55
Repurposing of the antibiotic nitroxoline for the treatment of mpox	55
Clinical Performance of OncoPredict HPV Screening Assay on Self‐Collected Vaginal and Urine Specimens Within the VALHUDES Framework	54
Preparation of highly specific monoclonal antibodies against SARS‐CoV‐2 nucleocapsid protein and the preliminary development of antigen detection test strips	54
Pulmonary infection in patients with severe fever with thrombocytopenia syndrome: A multicentre observational study	54
Advanced technologies towards improved HPV diagnostics	54
Human papillomavirus prevalence and genotype distribution in Liaocheng men between 2016 and 2022	54
Highly sensitive and rapid detection of SARS‐CoV‐2 via a portable CRISPR‐Cas13a‐based lateral flow assay	52
Epidemiological Characteristics of Neuro‐Specific Antibodies Following Viral Infections	52
Serum extracellular vesicle‐derived ASS1 is a promising predictor for the occurrence of HEV‐ALF	51
Genomic monitoring unveil the early detection of the SARS‐CoV‐2 B.1.351 (beta) variant (20H/501Y.V2) in Brazil	51
SARS‐CoV‐2 ORF3a inhibits cGAS‐STING‐mediated autophagy flux and antiviral function	51
Reflections Regarding Validation of New HPV Tests With Reduced HPV Genotypes: Report From an IARC Expert Consultation	51
Impact of nonalcoholic fatty liver disease status change on antiviral efficacy of nucleos(t)ide analogues in HBeAg‐positive chronic hepatitis B	51
SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID‐19: The International Study of Inflammation in COVID‐19	51
Association of Remdesivir use with bradycardia: A systematic review and meta‐analysis	50
Relative instantaneous reproduction number of Omicron SARS‐CoV‐2 variant with respect to the Delta variant in Denmark	50
Monkeypox Virus Subverts the Inflammatory Response of Macrophages at the Maternal‐Fetal Interface	50
Unraveling the Role of Mutations Outside the Basal Promoter and Precore Regions in the HBeAg‐Negative Stage of Chronic Hepatitis B	49
Serological responses to smallpox A33 antigen and monkeypox A35 antigen in healthy people and people living with HIV‐1 from Guangzhou, China	48
Cycle threshold values in RT‐PCR to determine dynamics of SARS‐CoV‐2 viral load: An approach to reduce the isolation period for COVID‐19 patients	48
Inhibiting cardiac autophagy suppresses Zika virus replication	48
Examination of control asymptomatic cohorts reveals heightened anti‐EBV and HHV‐6 A/B dUTPase antibodies in the aging populations	48
Issue Information	47
	47
COVID‐19 vaccinations: The unknowns, challenges, and hopes	47
Typing of alpha and beta coronaviruses by DNA barcoding of NSP12 gene	46
Viral fever of unknown origin during COVID‐19 and dengue outbreaks in Pakistan: Is media spreading panic during pandemic?	46
Dynamic m6A profiles reveal the role of YTHDC2‐TLR2 signaling axis in Talaromyces marneffei infection	46
Influenza is more severe than our newest enemy (COVID‐19) in hospitalized children: Experience from a tertiary center	46
The signature of SARS‐CoV‐2 evolution reflects selective pressures within human guts	46
Cover Image, Volume 95, Number 11, November 2023	45
Differential avidity determination of IgG directed towards the receptor‐binding domain (RBD) of SARS‐CoV‐2 wild‐type and its variants in one assay: Rational tool for the assessment of protective immun	45
High pre‐Delta and early‐Omicron SARS‐CoV‐2 seroprevalence detected in dried blood samples from Kinshasa (D.R. Congo)	45
Short and mid‐term SARS‐CoV‐2 antibody response after inactivated COVID‐19 vaccine in hemodialysis and kidney transplant patients	44
Research progress in Fc‐effector functions against SARS‐CoV‐2	44
Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge	43
Issue Information	43
Long‐term monitoring of the development and extinction of IgA and IgG responses to SARS‐CoV‐2 infection	43
Assessment of clinical outcomes in renal transplant recipients with COVID‐19	43
Issue Information	43
Differential diagnosis on measles and rubella discarded cases highlights a sharp increase in parvovirus B19 infections in Milan, Northern Italy, in the first months of 2024	43
Genomic epidemiology of the main SARS‐CoV‐2 variants in Italy between summer 2020 and winter 2021	42
Systematic Reevaluation of Repurposed Drugs Against the Main Protease of SARS‐CoV‐2 via Combined Experiments	42
Incomplete IgG avidity maturation after seasonal coronavirus infections	42
Cytoplasmic Shift of Interferon Regulatory Factors Co‐Evolved With Jawed Vertebrate Innate Immunity	42
Issue Information	41
Patterns of Co‐infection of HPV52 With Other HPV Genotypes and Their Risks of Cervical Precancer and Carcinoma	41
The Emerging Roles of Alternative Splicing in Human Oncovirus Infection	41
In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT‐qPCR assays for SARS‐CoV‐2 detection using whole genome sequencing	41
Evaluation of an E6/E7 PCR‐capillary electrophoresis fragment analysis in the genotyping of human papillomavirus in archival FFPE samples of oropharyngeal cancer	40
Omicron‐specific mRNA vaccine induced cross‐protective immunity against ancestral SARS‐CoV‐2 infection with low neutralizing antibodies	40
The impact of cerebrospinal fluid viral polymerase chain reaction testing on the management of adults with viral meningitis: A multi‐center retrospective study	40
Association between influenza vaccination and one‐year all‐cause and cardiovascular mortality risk: A self‐controlled case series and matched case‐control study	40
The effectiveness of inactivated SARS‐CoV‐2 vaccine (CoronaVac) on antibody response in participants aged 65 years and older	39
Multikingdom characterization of gut microbiota in patients with rheumatoid arthritis and rheumatoid arthritis‐associated interstitial lung disease	39
In the age of Omicron variant: Paxlovid raises new hopes of COVID‐19 recovery	39
Deciphering head and neck cancer microenvironment: Single‐cell and spatial transcriptomics reveals human papillomavirus‐associated differences	39
Corrigendum	38
Assessment of antibody kinetics in mpox cases with indigenously developed IgM and IgG ELISA	38
Issue Information	38
Can COVID‐19 cause atypical forms of pityriasis rosea refractory to conventional therapies?	38
Cocirculation of A(H3N2) and B/Victoria increased morbidity in hospitalized patients in the 2019–2020 A(H1N1)pdm09 predominant influenza season in Israel	38
Measles returns to the Democratic Republic of Congo: A new predicament amid the COVID‐19 crisis	37
Prolonged viral shedding in an immunocompromised Korean patient infected with hMPXV, sub‐lineage B.1.3, with acquired drug resistant mutations during tecovirimat treatment	37
Immunoassay and mass cytometry revealed immunological profiles induced by inactivated BBIBP COVID‐19 vaccine	37
Assessment of the cobas® HBV RNA investigational assay in the setting of nucleoside analog therapy cessation	37
Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis B	37
Small molecule RAF265 as an antiviral therapy acts against HSV‐1 by regulating cytoskeleton rearrangement and cellular translation machinery	37
The impact of statin therapy on in‐hospital prognosis and endothelial function of patients at high‐to‐very high cardiovascular risk admitted for COVID‐19	36
Measles in vulnerable populations: An outbreak in Roma settlements of Loire‐Atlantique, France, 2019	36
Reconstruction of the historic time course of blood‐borne virus contamination of clotting factor concentrates, 1974–1992	36
Viral metagenomics unveils MW (Malawi) polyomavirus infection in Brazilian pediatric patients with acute respiratory disease	36
Near full‐length genome analysis of HEV 4b subtype in pigs showed a similarity up to 99.944% compared to a patient in Guangdong province, China	36
Infection pattern and immunological characteristics of Epstein‐Barr virus latent infection in cervical squamous cell carcinoma	36
The resurgence of influenza A/H3N2 virus in Australia after the relaxation of COVID‐19 restrictions during the 2022 season	35
Duration from onset to discharge is longer in COVID‐19 patients with low blood regulatory T‐cell counts	35
Recombinant Zoster Vaccine Reduces All‐Cause Mortality, But Not Major Adverse Cardiovascular Events, in Patients With Immune‐Mediated Inflammatory Diseases Receiving Janus Kinase Inhibitors: A Large‐S	35
Phylogenetics and phylogeographic characteristics of coxsackievirus A16 in hand foot and mouth disease and herpangina cases collected in Beijing, China from 2019 to 2021	35

Detection of Polish cases of highly virulent subtype B of HIV‐1 originating in the Netherlands	35
Effect of different storage conditions on COVID‐19 RT‐PCR results	35
Hypertension is still a moving target in the context of COVID‐19 and post‐acute COVID‐19 syndrome	35
Incidences of new hepatitis B infection and anti‐hepatitis B core‐negative occult hepatitis B infection among Japanese blood donors in relation to anti‐hepatitis B surface antigen levels	35
Changing spectrum and mortality disparities of etiology of liver cirrhosis in Beijing, China	34
Methodological Considerations in Evaluating Recombinant Zoster Vaccine Effectiveness in COPD Patients	34
Performance evaluation of Elecsys SARS‐CoV‐2 Antigen immunoassay for diagnostic of COVID‐19	34
Alcohol‐Induced Dendritic Cells and Their Exosomes Promote T‐Cell Immunity in Hepatitis B Virus Transgenic Mice and Patients With Chronic Hepatitis B	34
Comparison of intracellular cytokine staining versus an ELISA‐based assay to assess CMV‐specific cell‐mediated immunity in high‐risk kidney transplant recipients	34
Consistency in human papillomavirus type detection between self‐collected vaginal specimens and physician‐sampled cervical specimens	34
Clinical performance of a newly developed domestic urine‐based HPV test for cervical cancer screening in China	34
Enhanced recombination among Omicron subvariants of SARS‐CoV‐2 contributes to viral immune escape	33
Comparative efficacy and safety of nirmatrelvir/ritonavir and molnupiravir for COVID‐19: A systematic review and meta‐analysis	33
Viral Interference and Coinfections: A Perspective From Hospital Surveillance of Respiratory Viruses	33
Long COVID syndrome‐associated brain fog	33
Two‐ and 3‐year outcomes in convalescent individuals with COVID‐19: A prospective cohort study	33
Response to the Korea National Committee on Immunization Programs' Letter	33
Resurgence of human metapneumovirus infection and influenza after three seasons of inactivity in the post‐COVID‐19 era in Hokkaido, Japan, 2022–2023	33
Modulation of Cell Cycle Kinases by Kaposi's Sarcoma‐Associated Herpesvirus	33
Risks of alopecia areata in long COVID: Binational population‐based cohort studies from South Korea and Japan	33
Mpox in Northeast Brazil: Spatiotemporal analysis and predictors associated with confirmed diagnosis	33
Associations of Lipid Profiles With the Onset of HEV‐Related Acute Liver Failure: A Multicenter Cohort Study	32
The potential of PCNA inhibition as a therapeutic strategy in cervical cancer	32
Simple, sensitive, and visual detection of 12 respiratory pathogens with one‐pot‐RPA‐CRISPR/Cas12a assay	32
Analysis of ACE2 and TMPRSS2 coding variants as a risk factor for SARS‐CoV‐2 from 946 whole‐exome sequencing data in the Turkish population	32
Genome and proteomic analysis of risk factors for fatal outcome in children with severe community‐acquired pneumonia caused by human adenovirus 7	32
The human papillomavirus late life cycle and links to keratinocyte differentiation	32
The global disease burden of varicella‐zoster virus infection from 1990 to 2019	31
Whole Genome Sequencing and Genetic Diversity of Respiratory Viruses Detected in Children With Acute Respiratory Infections: A One‐Year Cross‐Sectional Study in Senegal	31
Modulation of Covid‐19 cytokine storm by tocilizumab	31
Hantaan Virus (HTNV) Human Infection on Jeju Island, South Korea: Unique Phylogeny and Epidemiology of HTNV	31
Excess risk for acute myocardial infarction mortality during the COVID‐19 pandemic	31
A common mechanism links Epstein‐Barr virus infections and autoimmune diseases	31
Rhinovirus persistence during the COVID‐19 pandemic—Impact on pediatric acute wheezing presentations	31
Synergy Effects of HPV E6‐E7 Encoding mRNA and Nucleic Acid Immunostimulators Improve Therapeutic Potential in TC‐1 Graft Tumor	30
Oral Ad5 Vector‐Based SARS‐CoV‐2 Vaccine Effectively Induces Mucosal and Systemic Immune Responses in BALB/c Mice	30
A 10‐year Retrospective Analysis on HPV Genotype Switching in a Tertiary Center in China: Infection Characterization and Clinical Outcome	30
Adenovirus‐Specific T Cells in Adults Are Frequent, Cross‐Reactive to Common Childhood Adenovirus Infections and Boosted by Adenovirus‐Vectored Vaccines	30
Geriatric Nutritional Risk Index Plays Important Role in Predicting In‐Hospital Mortality in Patients With Severe Fever With Thrombocytopenia Syndrome: A Multi‐Center Observational Study	30
Issue Information	30
Vaccines for Covid‐19: An insight on their effectiveness and adverse effects	30
Comparison of the immunogenicity of nasal‐spray rVSV vector, adenovirus vector, and inactivated COVID‐19‐based vaccines in rodent models	30
Omicron variant of SARS‐CoV‐2: A pandemic of global concern warrants a cautious approach	30
Two novel recombinant human mastadenovirus D genotypes associated with acute respiratory illness	30
Correction to “Serum‐Derived Bovine Immunoglobulin Treatment in COVID‐19 Is Associated With Faster Resolution of Symptoms: A Randomized Pilot Clinical Trial”	30
Early recognition of a superinfection: This is the problem in the critically ill COVID‐19 patients	30
Comparing single versus multiple virus detection in pediatric acute gastroenteritis postimplementation of routine multiplex RT‐PCR diagnostic testing	29
A case of human buffalopox in Malappuram, India: The role of mpox surveillance in 2022	29
Lassa fever amidst the COVID‐19 pandemic in Africa: A rising concern, efforts, challenges, and future recommendations	29
The impact of the COVID‐19 pandemic on the global burden of influenza	29
GII.17[P17] and GII.8[P8] noroviruses showed different RdRp activities associated with their epidemic characteristics	29
Persistence of symptoms after improvement of acute COVID19 infection, a longitudinal study	29
Obstructive Sleep Apnea and Risk of Respiratory Syncytial Viral Infection: A Retrospective Multi‐Institution Cohort Study	29
SARS‐CoV‐2 RNA load in nasopharyngeal specimens from outpatients with breakthrough COVID‐19 due to Omicron BA.1 and BA.2	29
HBV PreC interacts with SUV39H1 to induce viral replication by blocking the proteasomal degradation of viral polymerase	29
Four conserved amino acids on human papillomavirus E6 predict clinical high‐risk types	29
Recent history and biology of H5N1 influenza A virus infections of farm animals (poultry, goat, alpacas, dairy cattle, barn cats) and humans in the United States of America	28
Appearance of extrapyramidal symptoms in adolescent psychiatry patients during COVID‐19 infection	28
Remdesivir for the Treatment of Human Coronavirus OC43 Encephalitis	28
Epidemiological characteristics and cerebrospinal fluid cytokine profiles of enterovirus encephalitis in children in Hangzhou, China	28
Acute gastroenteritis outbreak associated with multiple and rare norovirus genotypes after storm events in Santa Catarina, Brazil	28
Impact of heavy metals exposure on herpes simplex virus type I infection: A population‐based cross‐sectional study	28
Rapid detection of Ebolavirus using isothermal recombinase‐aided amplification	28
The binding profile of SARS‐CoV‐2 with human leukocyte antigen polymorphisms reveals critical alleles involved in immune evasion	28
Inside Back Cover Image, Volume 95, Number 1, January 2023	27
SARS‐CoV‐2 pseudovirus infectivity and expression of viral entry‐related factors ACE2, TMPRSS2, Kim‐1, and NRP‐1 in human cells from the respiratory, urinary, digestive, reproductive, and immune syste	27
Regarding the article prevalence and impact of viral myocarditis in patients with severe fever with thrombocytopenia syndrome by Hao et al	27
Response to the Letter to the Editor on “Clinical characteristics of unvaccinated or incompletely vaccinated children with neurological manifestations due to SARS‐CoV‐2 Omicron infection”	27
T cell epitopes are largely conserved in the SARS‐CoV‐2 Omicron subvariant (BA.1, BA.2, BA.3, and GKA)	27
The pathophysiological and immunological background of the monkeypox virus infection: An update	27
Issue Information	27
Molecular evolution and genomic characteristics of genotype H1 of measles virus	27
No health issue stands alone in Eastern Europe: Monkeypox emergence amidst socioeconomic and political crises	27
Sequential dynamics of virological and serological changes in the serum of SARS‐CoV‐2 infected patients	27
Erratum	27
Macrophages can transmit coxsackievirus B4 to pancreatic cells and can impair these cells	27
Correction to “Safety and immunogenicity of COVID‐19 vaccination in patients with hepatocellular carcinoma (CHESS‐NMCID 2101): A multicenter prospective study”	27
Evaluation of host cellular responses to Epstein–Barr virus (EBV) in adult lung transplant patients with EBV‐associated diseases	26
Change from low to out‐of‐season epidemics of influenza in China during the COVID‐19 pandemic: A time series study	26
Letter to the editor regarding the study on maternal HPV infection and the risk of congenital malformations	26
Enhanced Zika virus‐like particle development using Baculovirus spp. constructs	26
Human Cytomegalovirus Replication Enhanced By Placental MicroRNAs	26
Changes in cerebrospinal fluid proteome of patients with tick‐borne encephalitis	26
Estimating true prevalence through questionnaire data	26
Regaining virological suppression in a woman living with a six‐class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests	26
DENV‐1 genotype V circulation during the nonepidemic period in the Northeast of São Paulo State endemic area	26
Viral metagenomics enables accurate detection of viral pathogens in amniotic fluid samples from pregnant women with suspicion of congenital infection	26
Dengue and COVID‐19: A risk of coepidemic in Ethiopia	26
Clinical presentations of adult and pediatric SARS‐CoV‐2‐positive cases in a community cohort, Nashville, Tennessee	26
Heterologous Versus Homologous COVID‐19 Boosters: Immune Response Outcomes in Renal Transplant Recipients	26
High Torque teno virus load and outcome of patients undergoing allogeneic hematopoietic cell transplantation	26
Non‐liver‐related mortality in the DAA era: Insights from post‐SVR patients with and without previous HCC history	26
The impact of COVID‐19 on the patient, clinician, healthcare services and society: A patient pathway review	25
Bilateral non‐necrotizing herpetic retinopathy: Unusual initial presentation of ocular HSV‐1 infection	25
Comments on: Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV‐2 infection than negative patients and are associated to a worse outc	25